Cutaneous oncology program

皮肤肿瘤学项目

• 批准号: 6211795
• 负责人: JAMES E CLEAVER
• 金额: --
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-08-05 至 2002-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6211795
• 关键词: cell differentiation; clinical research; disease /disorder prevention /control; female; genetically modified animals; human subject; laboratory mouse; melanoma; mycosis fungoides lymphoma; neoplasm /cancer diagnosis; neoplasm /cancer therapy; neoplastic process; skin neoplasms; squamous cell carcinoma; xeroderma pigmentosum

Description: (Applicant's Description) Cutaneous malignancies represent the most common type of cancer in the United States. Understanding the biological basis of such cancers, leading to the development of improved therapies, is a major ongoing goal of the Cutaneous Oncology Program, which includes 23 investigators representing 10 departments and three off-site members. The Program includes basic scientists and clinicians with a common interest in understanding the biology of cutaneous neoplasms. One of the major long-term goals of the Cutaneous Oncology Program is to link the clinical activities in malignant melanoma, cutaneous T-cell lymphoma, and non-melanoma skin cancers with laboratory-based efforts aimed at prevention, improved diagnosis, and treatment of these diseases. The program has access to two large databases of patients with malignant melanoma and cutaneous T-cell lymphoma to assist in the examination of novel molecular determinants of tumor progression. Currently funded research undertaken by program members includes: molecular basis of basal cell nevus syndrome and xeroderma pigmentosum; calcium and keratinocyte differentiation; proteases and progression of squamous cell carcinoma; and multi-step cutaneous carcinogenesis in transgenic mice. Current cancer prevention and control efforts focus on understanding the biology of melanoma in women and improving the diagnostic skills of primary care physicians in the realm of non-melanoma skin cancers.

描述：（申请人的描述）皮肤恶性肿瘤是美国最常见的癌症类型。 了解此类癌症的生物学基础，从而开发出更好的疗法，是皮肤肿瘤学项目的一个主要持续目标，该项目包括代表10个部门的23名研究人员和3名非现场成员。 该计划包括基础科学家和临床医生在了解皮肤肿瘤的生物学的共同利益。皮肤肿瘤学项目的主要长期目标之一是将恶性黑色素瘤、皮肤T细胞淋巴瘤和非黑色素瘤皮肤癌的临床活动与旨在预防、改善诊断和治疗这些疾病的实验室工作联系起来。 该计划可以访问恶性黑色素瘤和皮肤T细胞淋巴瘤患者的两个大型数据库，以帮助检查肿瘤进展的新分子决定因素。目前由项目成员资助的研究包括：基底细胞痣综合征和着色性干皮病的分子基础;钙和角质形成细胞分化;蛋白酶和鳞状细胞癌的进展;以及转基因小鼠中的多步皮肤癌发生。 目前的癌症预防和控制工作重点是了解女性黑色素瘤的生物学，并提高初级保健医生在非黑色素瘤皮肤癌领域的诊断技能。